Mathematical modeling of tumor-induced angiogenesis

Journal of Mathematical Biology

Volumn 49, Issue 2, 2004, Pages 111-187

  Mantzaris, Nikos V ^a,b   Webb, Steve ^a,c   Othmer, Hans G ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Rice University   (United States)

^c LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

Angiogenesis; Mathematical modeling; Physiology; Review; Tumors

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC PROTEIN;

ANIMAL; BIOLOGICAL MODEL; EXTRACELLULAR MATRIX; HUMAN; MATHEMATICS; MICROCIRCULATION; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; THEORETICAL MODEL; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANGIOGENIC PROTEINS; ANIMALS; EXTRACELLULAR MATRIX; HUMANS; MATHEMATICS; MICROCIRCULATION; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION;

EID: 16644400591     PISSN: 03036812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00285-003-0262-2     Document Type: Review

References (266)

1. Adam, J.A., Bellomo, N.: A Survey of Models for Tumor-Immune System Dynamics. Boston: Birkhäuser, 1997
2. Ahmad, S.A., Liu, W., Jung, Y.D., Fan, F., Reinmuth, N., Bucana, C.D., Ellis, L.M.: Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma. A possible mechanism for the initiation of angiogenesis. Cancer 92 (5), 1138-1143 (2001)
3. Aiello, L.P., Pierce, E.A., Foley, E.D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G.L., Smith, L.E.: Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. USA 92, 104570-10461 (1995)
4. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., Walter, P.: Molecular Biology of The Cell. Fourth edn. New York and London: Garland, 2002
5. Allt, G., Lawrenson, J.G.: Pericytes: cell biology and pathology. Cells Tissues Organs 169 (1), 1-11 (2001)
6. Anderson, A.R.A., Chaplain, M.A.J.: A mathematical model for capillary network formation in the absence of endothelial cell proliferation. Appl. Math. Lett. 11, 109-114 (1998a)
7. Anderson, A.R.A., Chaplain, M.A.J., Garcia-Reimbert, C., Vargas, C.A.: A gradient driven mathematical model of antiangiogenesis. Math. Comput. Modeling 32, 1141-1152 (2000)
8. Anderson, A.R.A., Chaplain, M.A.J.: Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull. Math. Biol. 60 (5), 857-899 (1998b)
9. Andreasen, P.A., Kjoller, L., Christensen, L., Duffy, M.J.: The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72, 1-22 (1997)
10. Andres, J.L., Stanley, K., Cheifetz, S., Massague, J.: Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds to transforming growth factor-? J. Cell Biol. 109, 3137-3145 (1989)
11. Angiolillo, A.L., Sgadari, C., Taub, D.D., Liao, F., Farber, J.M., Maheshwar, S., Kleinman, H.K., Reaman, G.H., Tosato, G.: Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182, 155-162 (1995)
12. Asahara, T., Chen, D., Takahashi, T., Fujikawa, K., Kearney, M., Magner, M., Yancopoulos, G.D., Isner, J.M.: Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ. Res. 83 (3), 233-240 (1998)
13. Assoian, R.K., Komoriya, A., Meyers, C.A., Miller, D.M., Sporn, M.B.: Transforming growth factor-beta in human platelets. J. Biol. Chem. 258, 7155-7160 (1983)
14. Ausprunk, D.H., Folkman, J.: Migration and proliferation of endothelial cells in preformed and newly-formed blood vessels during tumor angiogenesis. Microvasc. Res. 14, 53-65 (1977)
15. Bach, T.L., Barsigian, C., Chalupowicz, D.G., Busler, D., Yaen, C.H., Grant, D.S., Martinez, J.: VE-cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gel. Exp. Cell Res. 238, 324-334 (1998)
16. Baish, J.W., Gazit, Y., Berk, D.A., Nozue, M., Baxter, L.T., Jain, R.K.: Role of tumor vascular architecture in nutrient and drug delivery: An invasion percolation-based network model. Microvasc. Res. 51, 327-346 (1996)
17. Balding, D., McElwain, D.L.S.: A mathematical model of tumour-induced capillary growth. J. Theor. Biol. 114, 53-73 (1985)
18. Balsari, A., Maier, J.A.M., Colnaghi, M.I., Menard, S.: Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breat carcinoma. Lab. Invest. 79, 897-902 (1999)
19. Barleon, B., Sozzani, S., Zhou, D., Weich, H.A., Mantovani, A., Marme, D.: Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87 (8), 3336-3343 (1996)
20. Baum, M., Chaplain, M.A.J., Anderson, A.R.A., Douek, M., Vaidya, J.S.: Does breast cancer exist in a state of chaos? Eur. J. Cancer 35, 886-891 (1999)
21. 1 integrins. Am. J. Pathol. 156, 1673-1683 (2000)
22. Benjamin, L.E., Golijanin, D., Itin, A., Pode, D., Keshet, E.: Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103 (2), 159-165 (1999)
23. Bicknell, R.J., Lewis, C.E., Ferrara, N., Ferrara, L. (eds.): Tumour Angiogenesis. Oxford: Oxford University Press, 1997
24. Bingle, L., Brown, N.J., Lewis, C.E.: The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196 (3), 254-265 (2002), Review
25. Bloch, W., Huggel, K., Sasaki, T., Grose, R., Bugnon, P., Addicks, K., Timpl, R., Werner, S.: The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing. FASEB J. 14 (15), 2373-2376 (2000)
26. Bohem, T., Folkman, J., Browder, T., O'Reilly, M.S.: Antiangiogenic therapy of experimental cancer does not acquire dryg resistance. Nature 390, 404-407 (1997)
27. Bornstein, P.: Diversity of function is inherent in matricellular protein: an appraisal of thrombospondin 1. J. Cell Biol. 130, 503-506 (1995)
28. Bouck, N., Stellmach, V., Hsu, S.C.: How tumors become angiogenic. Adv. Cancer Res. 69, 135-74 (1996)
29. Breier, G.: Angiogenesis in embryonic development - a review. Placenta 21, S11-S15 (2000a)
30. Breier, G.: Endothelial receptor tyrosine kinases involved in blood vessel development and tumor angiogenesis. Adv. Exp. Med. Biol. 476, 57-66 (2000b)
31. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164 (1994a)
32. Brooks, P.C., Clark, R.A., Cheresh, D.A.: Requirement of vascular integrin αvβ3 for angiogenesis. Science 264, 569-571 (1994b)
33. Brooks, P.C., Silletti, S., Schalscha, Von, T.L., Friedlander, M., Cheresh, D.A.: Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92, 391-400 (1998)
34. Brouty-Boye, D., Zetter, B.R.: Inhibition of cell motility by interferon. Science 208 (4443), 516-518 (1980)
35. Brown, L.F., Detmar, M., Claffey, K., Nagy, J.A., Feng, D., Dvorak, A.M., Dvorak, H.F.: VPF/VEGF: A multifunctional angiogenic cytokine. Chap. Regulation of Angiogenesis, 1997
36. Byrne, H.M., Chaplain, M.A.J.: Mathematical models for tumour angiogenesis: Numerical simulations and nonlinear wave solutions. Bull. Math. Biol. 57, 461-486 (1995)
37. Byrne, H.M., Chaplain, M.A.J.: Explicit solutions of a simplified model of capillary sprout growth during tumor angiogenesis. Appl. Math. Lett. 9 (1), 69-74 (1996)
38. Byzova, T.V., Goldman, C.K., Pampori, N., Thomas, K.A., Bett, A., Shattil, S.J., Plow, E.F.: A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol. Cell 6 (4), 851-860 (2000)
39. Cao, Y.: Endogenous angiogenesis inhibitors and their therapeutic implications. IJBCB 33, 357-369 (2001)
40. Cao, Y., Chen, C., Weatherbee, J.A., Tsang, M., Folkman, J.: Gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of lewis lung carcinoma in mice. J. Exp. Med. 182, 2069-2077 (1995)
41. Carlson, T.R., Feng, Y., Maisonpierre, P.C., Mrksich, M., Morla, A.O.: Direct cell adhesion to the angiopoietins mediated by integrins. J. Biol. Chem. 276 (28), 26516-26525 (2001)
42. Carmeliet, P., Jain, R.K.: Angiogenesis in cancer and other diseases. Nature 407, 249-257 (2000)
43. Chaplain, M.A.J.: Mathematical modelling of angiogenesis. J. Neuro-Oncology 50, 37-51 (2000)
44. Chaplain, M.A.J., Anderson, A.R.A.: The mathematical modeling, simulation and prediction of tumor-induced angiogenesis. Invas. Metast. 16, 222-234 (1996)
45. Chaplain, M.A.J., Anderson, A.R.A.: Modeling the growth and form of capillary networks. Chichester: Wiley. Chap. On Growth and Form: Spatio-Temporal Pattern Formation in Biology, pp. 225-249 (1999)
46. Chaplain, M. A.J., Orme, M.E.: Mathematical modeling of tumor-induced angiogenesis. Boston: Birkhauser. Chap. Vascular Morphogenesis: In vivo, in vitro, in mente, pp. 205-240 (1998)
47. Chaplain, M.A.J., Giles, S.M., Sleeman, B.D., Jarvis, R.J.: A mathematical analysis of a model for tumour angiogenesis. J. Math. Biol. 33, 744-770 (1995)
48. Chen, C., Parangi, S., Tolentino, M.J., Folkman, J.: A strategy to discover circulating angiogenesis inhibitors generated by human tumors. Cancer Res. 55, 4230-4233 (1995)
49. Christofori, G.: The Role of Fibroblast Growth Factors in Tumor Progression and Angiogenesis. R. bicknell, ce lewis and n. ferrara edn. Oxford University Press. Chap. Tumor Angiogenesis (1996)
50. Claesson-Wells, L., Wells, M., Ito, N., Anand-Apte, B., Soker, S., Zetter, B., O'Reilly, S., Folkman, J.: Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. PNAS USA 95, 5579-5583 (1998)
51. Clapp, C., Martial, J.A., Guzman, R.C., Rentierdelrue, F., Weiner, R.: The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133, 1292-1299 (1993)
52. Coleman, K.R., Braden, G.A., Willingham, M.C. et al.: Vitaxin, a humanized monoclonal antibody to the vitronectin receptor (α v β 3), reduces neointimal hyperplasia and total vessel area after balloon injury in hypercholesterolemic rabbits. Circ. Res. 84, 1268-1276 (1999)
53. Colorado, P.C., Torre, A., Kamphaus, G., Maeshima, Y., Hopfer, H., Takahashi, K., Volk, R., Zamborsky, E.D., Sarkar, S., Herman, P.K., Ericksen, E.M., Dhanabal, M., Simons, M., Post, M., Kufe, D.W., Weichselbaum, R.R., Sukhatme, V.P., Kalluri, R.: Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res. 60, 2520-2526 (2000)
54. Cory, A.H., Owen, T.C., Barltrop, J.A., Cory, J.G.: Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 3, 207-212 (1991)
55. Coussens, L.M., Werb, Z.: Matrix metalloproteinases and the development of cancer. Chem. Biol. 3 (11), 895-904 (1996)
56. Dallon, J.C., Othmer, H.G.: A discrete cell model with adaptive signalling for aggregation of dictyostelium discoideum. Philos. Trans. R Soc. Lond. B Biol. Sci 352 (1351), 391-417 (1997)
57. D'Amato, R.J., Loughnan, M.S., et al., Flynn., E.: Thalidomide is an inhibitor of angiogenesis. Proc. Natl. Acad. Sci. USA 91, 4082-4085 (1994)
58. Dameron, K.M., Volper, O.V., Tainsky, M.A., Bouck, N.: Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582-1584 (1994)
59. 1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Exp. Cell Res. 224, 39-51 (1996)
60. Detmar, M.: The role of VEGF and thrombospondins in skin angiogenesis. J. Dermatol. Sci. 24 (84), S78-S (2000)
61. Dhanapal, M., Ramchandran, R., Waterman, M.J., Lou, H., Knebelmann, B., Segal, M., Sukhatme, V.P.: Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 274, 11721-11726 (1999)
62. Doki, Y., Shiozaki, H., Tahara, H., Imoue, M., Iihara, H., Oka, K., Kadowaki, T., Takeichi, M., Takesada, M.: Correlation between E-cadherin expression and invasiveness in vitro in human esophageal cancer cell line. Cancer Res. 53, 3421-3426 (1993)
63. Dubois-Stringfellow, N., Jonczyk, J., Bautch, V.L.: Perturbations in the fibrinolytic pathway aboliah cyst formation but not capillary-like organization of cultured murine endothelial cells. Blood 83, 3206-3217 (1994)
64. Dvorak, H.F., Brown, L.F., Detmar, M., Dvorak, A.M.: Vascular permeability factor/vascular endothelail growth factor, microvascular hyperpermeability, and angiogenesis. AM. J. Pathol. 146, 1029-1039 (1995)
65. Eliceiri, B.P., Paul, R., Schwartzberg, P.L., Hood, J.D., Leng, J., Cheresh, D.A.: Selective requirement for src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell 4 (6), 915-924 (1999)
66. Enholm, B., Paavonen, K., Ristimaki, A., Kumar, V., Gunji, Y., Klefstrom, J., Kivinen, L., Laiho, M., Olofsson, B., Joukov, V., Eriksson, U., Alitalo, K.: Comparison of VEGF, VEGF-B, VEGF-C and ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 14 (20), 2475-2483 (1997)
67. Ergun, S., Kilic, N., Wurmbach, J.H., Ebrahimnejad, A., Fernando, M., Sevinc, S., Kilic, E., Chalajour, F., Fiedler, W., Lauke, H., Lamszus, K., Hammerer, P., Weil, J., Herbst, H., Folkman, J.: Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes. Angiogenesis 4 (3), 193-206 (2001)
68. Etoh, T., Shibuta, K., Barnard, G. G., Kitano, S., Mori, M.: Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. Clin. Cancer Res. 6 (9), 3545-3551 (2000)
69. Ferrara, N.: Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int. 56, 794-814 (1999)
70. Ferrara, N.: VEGF: an update on biological and therapeutic aspects. Curr. Opin. Biotechnol. 11, 617-624 (2000)
71. Ferrara, N., Davis-Smyth, T.: The biology of vascular endothelial growth factor. Endocr. Rev. 18, 4-25 (1997)
72. Ferrara, N., Keyt, B.: VEGF: Basic biology and clinical implications. Chap. Regulation of Angiogenesis, 1997
73. Flaumenhaft, R., Moscatelli, D., Saksela, O., Rifkin, D.B.: Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J. Cell Physiol. 75-81 (1989)
74. Folkman, J.: The vascularization of tumors. Cancer Biology: Readings from Scientific American 115-124 (1986)
75. Folkman, J.: Therapeutic implications. N. Engl. J. Med. 285, 1182-1186 (1971)
76. Folkman, J.: The vascularization of tumors. Sci. Am. 234, 58-64 (1976)
77. Folkman, J.: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1, 27-31 (1995a)
78. Folkman, J.: Clinical applications of research on angiogenesis. N. Engl. J. Med. 333, 1757-1763 (1995b)
79. Folkman, J., Haudenschild, C.: Angiogenesis in vitro. Nature 288, 551-556 (1980)
80. Folkman, J., Klagsbrun, M.: Angiogenic factors. Science 235, 442 (1987)
81. Folkman, J., Mendelsohn, J., Howley, P.M., Israel, M.A., Liotta, L.A.: Tumor angiogensis. The molecular basis of cancer. Eds. WB Saunders: Philadelphia 206-232 (1995)
82. Fong, G.H., Rossant, J., Gertenstein, M., Breitman, M.L.: Role of the flt-1 receptor tyrosine kinase in regulating assembly of vascular endothelium. Nature 376, 66-70 (1995)
83. Fong, T.A., Shawver, L.K., et al., Sun., L.: SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization. Cancer Res. 59, 9-106 (1999)
84. Franz, C.M., Jones, G.E., Ridley, A.J.: Cell migration in development and disease. Dev. Cell. 2 (2), 153-158 (2002)
85. Frater-Schroeder, M., Mueller, G., Birchmeier, W., Boehlen, P.: Transforming growth factor-β inhibits endothelial cell proliferation. Biochem. Biophys. Res. Commun. 137, 295 (1986)
86. Frazier, W.A.: Thrombospondin: A modular adhesive glycoprotein of platelets and nucleated cells. J. Cell Biol. 105, 625-632 (1987)
87. Frolik, C.A., Dart, L.L., Meyers, C.A., Smith, D.M., Sporn, M.B.: Purification and initial characterization of a type beta transforming growth factor from human placenta. Proc. Natl. Acad. Sci. 80, 3676-3680 (1983)
88. Fukata, Y., Amano, M., Kaibuchi, K.: Rho-rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends. Pharmacol. Sci. 22 (1), 32-39 (2001)
89. Funamoto, S., Milan, K., Meili, R., Firtel, R.A.: Role of phosphatidylinositol 3′ kinase and a downstream pleckstrin homology domain-containing protein in controlling chemotaxis in dictyostelium. J. Cell Biol. 153 (4), 795-810 (2001)
90. Furumatsu, T., Yamaguchi, N., Nishida, K., Kawai, A., Kunisada, T., Namba, M., Inoue, H., Ninomiya, Y.: Endostatin inhibits adhesion of endothelial cells to collagen I via alpha(2)beta(1) integrin, a possible cause of prevention of chondrosarcoma growth. J. Biochem. (Tokyo) 131 (4), 619-626 (2002)
91. Gamble, J.R., Matthias, L.J., Meyer, G., Kaur, P., Russ, G., Faull, R., Berndt, M.C., Vadas, M.A.: Regulation of in vitro capillary tube formation by anti-integrin antibodies. J. Cell Biol. 121, 931-943 (1993)
92. Gazit, Y., Berk, D.A., Leunig, M., Jain, R.K., Baxter., L.T.: Scale-invariant behavior and vascular network formation in normal and tumor tissue. Phys. Rev. Lett 75, 2428-2431 (1995)
93. Gerber, H.P., Hillan, K.J., Ryan, A.M., Kowalski, J.K., Keller, G.A., Rangell, L., Wright, B.D., Radtke, F., Aguet, M., Ferrara, N.: VEGF is required for growth and survival in neonatal mice. Development 126, 1149-1159 (1999)
94. Gimborne, M.A., Cotran, R.S., Leapman, S.B., Folkman, J.: Tumor growth and neovasularization: An experimental model using the rabbit cornea. J. Nat. Can. Inst. 52, 413-427 (1974)
95. Goede, V., Brogelli, L., Ziche, M., Augustin, H.G.: Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int. J. Cancer 82 (5), 765-770 (1999)
96. Good, D.J., Polverini, P.J., Rastinejad, F., Beau, M., Le, M., Lemons, R.S., Frazier, W.A., Bouck, N.P.: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA 87, 6624-6628 (1990)
97. Gospodarowicz, D., Ferrara, N., Schweigerer, L., Neufeld, G.: Structual characterization and biological functions of fibroblast growth factor. Endocr. Rev. 8, 95-113 (1987)
98. Goto, F., Goto, K., Weindel, K., Folkman, J.: Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab. Invest. 69, 508-517 (1993)
99. Griffioen, A.W., Molema, J.: Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmaco. Revs. 52 (2), 237-268 (2000), Review
100. Gupta, S.K., Hassel, T., Singh, J.P.: A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc. Natl. Acad. Sci. USA 92, 7799-7803 (1995)
101. Han, Z.C., Liu, Y.: Angiogenesis:state of the art. Int. J. Hematology 70, 68-82 (1999)
102. Hanahan, D.: Signaling vascular morphogenesis and maintenance. Science 227, 48-50 (1997)
103. Hanahan, D., Folkman, J.: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364 (1996)
104. Hanai, J., Dhanabal, M., Karumanchi, S.A., Albanese, C., Waterman, M., Chan., B.: Ramchandran R, pestell R, sukhatme VP. endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1. J. Biol. Chem. 277 (19), 16464-16469 (2002)
105. Higgs, H.N., Pollard, T.D.: Regulation of actin filament network formation through ARP2/3 complex: activation by a diverse array of proteins. Annu. Rev. Biochem. 70, 649-676 (2001), Review
106. Hildenbrand, R., Wolf, G., Bohme, B., Bleyl, U., Steinborn, A.: Urokinase plasminogen activator receptor (CD87) expression of tumor-associated macrophages in ductal carcinoma in situ, breast cancer, and resident macrophages of normal breast tissue. J. Leukoc. Biol. 66 (1), 40-49 (1999)
107. Hirschi, K.K., D'Amore, P.A.: Pericytes in the microvasculature. Cardiovasc. Res. 32 (4), 687-698 (1996)
108. Hirschi, K.K., Rohovsky, S.A., D'Amore, P.A.: Cell-cell interactions in vessel assembly: a model for the fundamentals of vascular remodelling. Transpl. Immunol. 3, 177-178 (1997)
109. Hirschi, K.K., Rohovsky, S.A., Beck, L.H., Smith, S.R., D'Amore, P.A.: Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ. Res. 84 (3), 298-305 (1999)
110. Holmes, M.J., Sleeman, B.D.: A mathematical model of tumour angiogenesis incorporating cellular traction and viscoelastic effects. J. Theor. Biol. 202 (2), 95-112 (2000)
111. Homandberg, G.A., Williams, J.E., Grant, D.B.S., Eisenstein, R.: Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth. Am. J. Pathol. 120, 327-332 (1985)
112. Houck, K.A., Ferrara, N., Winer, J., Li, B., Leung, D.W.: The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5, 1806-1814 (1991)
113. Houck, K.A., Leung, D.W., Rowland, A.M., Winer, J., Ferrara, N.: Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267, 26031-26037 (1992)
114. Hynes, R.O.: Integrins: versatility, modulation and signaling in cell adhesion. Cell 69, 11-25 (1992)
115. Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., Folkman, J.: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348, 555-557 (1990)
116. Inoue, K., Perrotte, P., Wood, C.G., Slaton, J.W., Sweeney, P., Dinney, C.P.: Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor. Clin. Cancer Res. 6, 4422-4431 (2000)
117. Jiang, M.C., Liao, C.F., Lee, PH.: Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells. Biochem. Biophys. Res. Commun. 282, 671-677 (2001)
118. Jimenez, B., Volpert, O.V.: Mechanistic insights on the inhibition of tumor angiogenesis. J. Mol. Med. 78, 663-672 (2001)
119. Johnson, D.E., Williams, L.T.: Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60, 1-41 (1993), Review
120. Kamphaus, G.D., Colorado, P.C., Panka, D.J., Hopfer, H., Ramchandran, R., Torre, A., Maeshima, Y., Mier, J.W., Sukhatme, V.P., Kalluri, R.: Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J. Biol. Chem. 275, 1209-1215 (2000)
121. Karihaloo, A., Karumanchi, S.A., Barasch, J., Jha, V., Nickel, C.H., Yang, J., Grisaru, S., Busch, K.T., Nigam, S., Rosenblum, N.D., Sukhatme, V.P., Cantley, L.G.: Endostatin regulates branching morphogenesis of renal epithelial cells and ureteric bud. Proc. Natl. Acad. Sci. USA 98 (22), 12509-12514 (2001)
122. Kiani, M., Hudetz, A.: Computer simulation of growth of anastomosing microvascular networks. J. Theor. Biol. 150, 547-560 (1991)
123. Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S., HS, Ferrara, N.: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362, 841-844 (1993)
124. Kim, Y.M., Jang, J.W., Lee, O.H., Yeon, J., Choi, E.Y, Kim, K.W., Lee, S.T., Kwon, Y.G.: Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. Cancer Res. 60 (19), 5410-5413 (2000)
125. Kiosses, W.B., Shattil, S.J., Pampori, N., Schwartz, M.A.: Rac recruits high-affinity integrin alphavbeta3 to lamellipodia in endothelial cell migration. Nat. Cell Biol. 3 (3), 316-320 (2001)
126. Koblizek, T.I., Weiss, C., Yancopoulos, G.D., Deutsch, U., Risau, W.: Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr. Biol. 8 (9), 529-532 (1998)
127. Koga, K., Todaka, T., Morioka, M., Hamada, J., Kai, Y., Yano, S., Okamura, A., Takakura, N., Suda, T., Ushio, Y.: Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis. Cancer Res. 61 (16), 6248-6254 (2001)
128. Konerdig, M.A., Ackern, Van, C., Steinberg, F., Streffer, C.: The development of the tumoue vascular system: 2-D and 3-D approaches to network formation in human xenografted tumours. M.e. maragoudakis et al edn. New York: Plenum Press. Chap, angiogenesis in health and disease, 1992
129. Koolwijk, P., Hanemaaijer, R., Van Hinsbergh, V.W.M.: Proteases and angiogenesis: Regulation of plasminogen activators and matrix metalloproteases by endothelial cells. NATO ASI series. Series A, Life sciences 298, 241 (1998)
130. Kremer, C., Breier, G., Risau, W., Plate, K.H.: Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system. Cancer Res. 57, 3852-3859 (1997)
131. Kukk, E., Wartiovaara, U., Gunji, Y., Kaukonen, J., Buhring, H.J., Rappold, I.: Matikainen MT, vihko P, partanen J, palotie A, alitalo K, alitalo R. analysis of tie receptor tyrosine kinase in haemopoietic progenitor and leukaemia cells. Br. J. Haematol. 98 (1), 195-203 (1997)
132. Landini, G., Misson, G.: Simulation of corneal neovascularization by inverted diffusion limited aggregation. Invest. Ophthalmol. Vis. Sci. 34, 1872-1875 (1993)
133. Lauffenburger, D.A., Horwitz, A.F.: Cell migration: a physically integrated molecular process. Cell 84 (3), 359-369 (1996)
134. Lauren, J., Gunji, Y., Alitalo, K.: Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? Am. J. Pathol. 5, 1333-1339 (1998), Review
135. Lawrence, D.A., Pircher, R., Kryceve-Martinerie, C., Petzelbauer, P.: Normal embryo fibroblasts release transforming growth factors in latent form. J. Cell Physiol. 121, 184-188 (1984)
136. Lee, S.J., Jang, J.W., Kim, Y.M., Lee, H.I., Jeon, J.Y., Kwon, Y.G., Lee, S.T.: Endostatin binds to the catalytic domain of matrix metalloproteinase-2. FEBS Lett 519 (1-3), 147-152 (2002)
137. Leek, R.D., Lewis, C.E., Whitehouse, R., Greenall, M., Clarke, J., Harris, A.L.: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56 (20), 4625-4629 (1996)
138. Levine, H.A., Sleeman, B.D., Nilsen-Hamilton, M.: A mathematical model for the roles of pericytes and macrophages in angiogenesis. I. the role of protease inhibitors in preventing angiogenesis. Math. Biosci. 168, 77-115 (2000)
139. Levine, H.A., Pamuk, S., Sleeman, B.D., Nilsen-Hamilton, M.: Mathematical modeling of capillary formation and development in tumor angiogenesis: penetration into the stroma. Bull. Math. Biol. 63, 801-863 (2001a)
140. Levine, H.A., Sleeman, B.D., Nilsen-Hamilton, M.: Mathematical modeling of the onset of capillary formation initiating angiogenesis. J. Math. Biol. 42, 195-238 (2001b)
141. Levine, H.A., Tucker, A.L., Nilsen-Hamilton, M.: A mathematical model for the role of cell signal transduction in the initiation and inhibition of angiogenesis. Growth Factors 20 (4), 155-175 (2002)
142. Lewis, J.S., Landers, R.J., Underwood, J.C., Harris, A.L., Lewis, C.E.: Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J. Pathol. 192 (2), 150-158 (2000)
143. Liekens, S., De Clercq. E., Neyts, J.: Angiogenesis: regulators and clinical applications. Biochem. Pharmacol. 61, 253-270 (2001)
144. Liotta, L.A., Stetler-Stevenson, W.G.: Principles of molecular cell biology of cancer: cancer metastasis. Philadelphia: Lippincott. Chap. Cancer: Principles and Practice of Oncology, pp. 134-149 (1993)
145. Lipponen, P.K.: Expression of cathepsin D in transitional cell bladder tumours. J. Pathol. 178 (1), 59-64 (1996)
146. Lobov, I.B., Brooks, P.C., Lang, R.A.: Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc. Natl. Acad. Sci. U S A 99 (17), 11205-11210 (2002)
147. Lowe, P.M., Lee, M.L., Jackson, C.J., To, S.S., Cooper, A.J., Schrieber, L.: The endothelium in psoriasis. Br. J. Dermatol. 132, 497-505 (1995)
148. Lu, H., Mabilat, C., Yeh, P., Guitton, J.D., Li, H., Pouchelet, M., Shoevaert, D., Legrand, Y., Soria, J., Soria, C.: Blockage of urokinase receptor reduces in vitro the mobility and the deformability of endothelial cells. FEBS Lett 380, 21-24 (1996)
149. Lyons, R.M., Keski-Oja, J., Moses, H.L.: Proteolytic activation of latent transforming growth factor-Grβ from fibroblast-conditioned medium. J. Cell Physiol. 106, 1659-1665 (1988)
150. Maeshima, Y., Colorado, P.C., Kalluri, R.: Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J. Biol. Chem. 275, 23745-23750 (2000)
151. Maione, T.E., Gray, G.S., Petro, J., Hunt, A.J., Donner, A.L., Bauer, S.I., Carson, H.F., Sharpe, R.J.: Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247, 77-79 (1990)
152. Maisonpierre, P.C., Suri, C., Jones, P.F., Bartunkova, S., Wiegand, S.J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T.H., Papadopoulos, N., Daly, T.J., Davis, S., Sato, T.N., Yancopoulos, G.D.: Angiopoietin-2, a natural antagonist for tie2 that disrupts in vivo angiogenesis. Science 277 (5322), 55-60 (1997)
153. Mandriota, S.J., Pepper, M.S.: Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ. Res. 83 (8), 852-859 (1998)
154. Manoussaki, D., Lubkin, S.R., Vernon, R.B., Murray, J.D.: A mathematical model for the formation of vascular networks in vitro. Acta Biotheoretica 44, 271-282 (1996)
155. Mantovani, A.: Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest. 1, 5-16 (1994)
156. Matsumura, T., Wolff, K., Petzelbauer, P.: Endothelial cell tube formation depends on cadherin 5 and CD31 intercations with filamentous actin. J. Immunol. 158, 3408-3416 (1997)
157. McDougall, S.R., Anderson, A.R.A., Chaplain, M.A.J., Sherratt, J.A.: Mathematical modelling of flow through vascular networks: Implications for tumour-induced angiogenesis and chemotherapy strategies. Bull. Math. Biol. 64, 673-702 (2002)
158. Meyer, G.T., Matthias, L.J., Noack, L., Vadas, M.A., Gamble, J.R.: Lumen formation during angiogenesis in vitro involves phagocytic activity, formation and secretion of vacuoles, cell death, and capillary tube remodelling by different populations of endothelial cells. Anat. Record 249 (3), 327-340 (1997)
159. Mignatti, P., Rifkin, D.B.: Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 117-137 (1996)
160. Moldovan, N.I.: Role of monocytes and macrophages in adult angiogenesis: A light at the tunnel's end. J. Hematother. Stem. Cell Res. 11 (2), 179-194 (2002), Review
161. Monier-Gavelle, F., Duband, J.L.: Control of N-cadherin mediated intercellular adhesion in migrating neural crest cells in vitro. J. Cell Sci. 3839-3853 (1995)
162. Montesano, R., Pepper, M.S., Mohle-Steinlein, U., Wagner, L., Orci, W., Risau, E.F.: Increased proteolytic activity is responsible for the aberrant morphogenetic behaviour of endothelial cells expressing middle T oncogene. Cell 62, 435-445 (1990)
163. Moscatelli, D., Rifkin, D.B.: Membrane and matrix localization of proteinases - a common theme in tumor-cell invasion and angiogenesis. Biochem. Biophys. Acta 948 (1), 67-85 (1988)
164. Moscatelli, D., Presta, M., Joseph-Silverstein, J., Rifkin, D.B.: Both normal and tumor cells produce basic fibroblast growth factor. J. Cell Physiol. 129, 273-276 (1986)
165. Murray, J.D., Oster, G.F.: Cell traction models for generation of pattern and form in morphogenesis. J. Math. Biol. 19, 265-279 (1984)
166. Murray, J.D., Swanson, K.R.: On Growth and Form: Spatio-Temporal Pattern Formation in Biology. Chichester: Wiley. Chap. On the mechanochemical theory of biological pattern formation with applications to wound healing and angiogenesis, pp. 251-285 (1999)
167. Murray, J.D., Oster, G.F., Harris, A.K.: A mechanical model for mesenchymal morphogenesis. J. Math. Biol. 17 (1), 125-129 (1983)
168. Muthukkaruppan, V.R., Kubai, L., Auerbach, R.: Tumor-induced neovascularization in the mouse eye. J. Natl. Cancer Inst. 69, 699-705 (1982)
169. Nakahara, H., Howard, L., Thompson, E.W., Seiki, H., Sato, M., Yeh, Y., Chen, W.: Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloproteinase docking to invadopodia is required for cell invasion. Proc. Natl. Acad. Sci. USA 94 (15), 7959-7964 (1997)
170. Nekka, F., Kyriakos, S., Kerrigan, C., Cartilier, L.: A model of growing vascular structures. Bull. Math. Biol. 58, 409-424 (1996)
171. Neufeld, G., Cohen, T., Gengrinovitch, S., Gluzman-Poltorak, Z.: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9-22 (1999)
172. Norby, K.: Angiogenesis: new aspects relating to its initiation and control. APMIS 105, 417-437 (1997)
173. Norrby, K.: Mast cells and angiogenesis. APMIS 110 (5), 355-71 (2002)
174. Olsen, L., Sherratt, J. A., Maini, P. K., Arnold, F.: A mathematical model for the capillary endothelial cell-extracellular matrix interactions in wound-healing angiogenesis. IMA J. Math. Appld. Med. Biol. 14, 261-281 (1997)
175. O'Reilly, M.S.: Angiostatin: An endogenous inhibitor of angiogenesis and of tumor growth. Chap. Regulation of Angiogenesis, 1997
176. O'Reilly, M.S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R.A., Moses, M., Lane, W.S., Cao, Y., Sage, E.H., Folkman, J.: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma. Cell 79, 315-328 (1994)
177. O'Reilly, M.S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W.S., Flynn, E., Birkhead, J.R., Olsen, J., Folkman, B.R.: Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285 (1997)
178. O'Reilly, M.S., Pirie-Shepherd, S., Lane, W.S., Folkman, J.: Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science 285, 1926-1928 (1999)
179. Orlidge, A., D'Amore, P.A.: Inhibition of capillary endothelial cell
180. Orme, M.E., Chaplain, M.A.J.: A mathematical model of the first steps of tumour-related angiogenesis: Capillary sprout formation and secondary branching. IMA J. Math. Appld. Med. Biol. 13, 73-98 (1996)
181. Orme, M.E., Chaplain, M.A.J.: Two-dimensional models of tumour angiogenesis and anti-angiogenesis strategies. IMA J. of Math. Appld. Med. Biol. 14, 189-205 (1997)
182. Oster, G.F., Murray, J.D., Harris, A.K.: Mechanical aspects of mesenchymal morphogenesis. J. Embryol. Exp. Morph. 78, 83-125 (1983)
183. Othmer, Hans, G., Stevens, Angela: Aggregation, blowup, and collapse: The ABC's of taxis in reinforced random walks. SIAM J. Appld. Math. 57 (4), 1044-1081 (1997)
184. Painter, K.J., Maini, P.K., Othmer, H.G.: Development and applications of a model for cellular response to multiple chemotactic cues. J. Math. Biol. 41 (4), 285-314 (2000)
185. Papetti, M., Herman, I.M.: Mechanisms of normal and tumor-derived angiogenesis. Am J. Physiol. Cell Physiol. 282, 5 (970), C947-C970 (2002)
186. Parent, C.A., Devreotes, P.N.: A cell's sense of direction. Science 284 (5415), 765-770 (1999)
187. Patterson, B.C., Sang, Q.A.: Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 272 (46), 28823-28825 (1997)
188. Paweletz, N., Knierim, M.: Tumor-related angiogenesis. Crit. Rev. Onco./Hema. 9, 197-242 (1989)
189. Pennington, D.W., Lopez, A.R., Thomas, P.S., Ryan, U.S.: Stimulation of rat endothelial cell transforming growth factor-Grβ production by bleomycin. J. Clin. Invest. 83, 148-154 (1991)
190. Pepper, M.S., Montesano, R.: Proteolytic balance and capillary morphogenesis. Cell Diff. Develop. 32, 319-328 (1990)
191. Pepper, M.S., Ferrara, N., Orci, L., Montesano, T.: Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun. 189, 824-831 (1992)
192. Pepper, M.S., Montesano, R., Mandriota, S.J., Orci, L., Vassalli, J.: Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 49, 138-162 (1996)
193. Peters, K.G., Coogan, A., Berry, D., Marks, J., Iglehart, J.D., Kontos, C.D., Rao, P., Sankar, S., Trogan, E.: Expression of tie2/tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis. Br. J. Cancer 77 (1), 51-56 (1998)
194. Pettet, G.J., Chaplain, M.A.J., McElwain, D.L.S., M., H., Byrne: A model of wound-healing angiogenesis in soft tissue. Math. Biosc. 136 (1), 35-63 (1996)
195. Pike, S.E., Yao, L., Jones, K.D., Cherney, B., Appella, E., Sakaguchi, K., Nakhasi, H., Teruya-Feldstein, J., Wirth, P., Gupta, G., Tosato, G.: Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J. Exp. Med. 188, 2349-2356 (1998)
196. Pircher, R., Jullien, P., Lawrence, D.: Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem. Biophys. Res. Commun 136, 30-37 (1986)
197. Poltorak, Z., Cohen, T., Neufeld, G.: The VEGF splice variants: properties, receptors, and usage for the treatment of ischemic diseases. Herz 25, 126-129 (2000)
198. Polverini, P.J.: Cellular adhesion molecules. Newly identified mediators of angiogenesis. Am. J. Pathol. 148, 1023-1029 (1996a)
199. Polverini, P.J.: How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases. Eur. J. Cancer 14, 2430-2437 (1996b)
200. Presta, M., Maier, J.A.M., Ragnotti, G.: The mitogenic signally pathway but not the plasminogen activator-induced pathway of basic fibroblast growth factor is mediated through protein kinase C in fetal bovine aortic endothelial cells. J. Cell Biol. 109, 1877-1884 (1989)
201. Ramchandran, R., Dhanabal, M., Volk, R., Waterman, W.J., Segal, M., Lu, H., Knebelmann, B., Sukhatme, V.P.: Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem. Biophys. Res. Commun. 255, 735-739 (1999)
202. Rastinejad, F., Polverini, P.J., Bouck, N.P.: Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56, 345-355 (1989)
203. Rehn, M., Veikkola, T., Kukk-Valdre, E., Nakamura, H., Ilmonen, M., Lombardo, C.: Pihlajaniemi T, Alitalo K, Vuori K. interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl. Acad. Sci. U S A 98 (3), 1024-1029 (2001)
204. Rifkin, D.B., Moscatelli, D.: Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109, 1-6 (1989)
205. Ristimaki, A., Narko, K., Enholm, B., Joukov, V, Alitalo, K.: Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J. Biol. Chem. 273 (14), 8413-8418 (1998)
206. Roberts, A.B., Sporn, M.B., Assoian, R.K., Smith, J.M., Roche, N.S., Wakefield, L.M., Heine, U.I.: Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83, 4167 (1986)
207. Ruoslahti, E.: How cancer spreads. Scientific American 275, 150-154 (1996)
208. 1 integrin expression results in reduced cyst formation, failure of hepatocyte growth factor scatter factor-induced branching morphogenesis, and increased apoptosis. J. Cell Sci. 108, 3531-3540 (1995)
209. Saksela, O., Rifkin, D.B.: Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plaminogen activator-mediated proteolytic activity. J. Cell Biol. 110, 767-775 (1990)
210. Saksela, O., Moscatelli, D., Sommer, A., Rifkin, D.B.: Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol. 107, 743-751 (1998)
211. Salcedo, R., Ponce, M.L., Young, H.A., Wasserman, K., Ward, J.M., Kleinman, H.K., Oppenheim, J.J., Murphy, W.J.: Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96 (1), 34-40 (2000)
212. Sato, A., Iwama, A., Takakura, N., Nishio, H., Yancopoulos, G.D., Suda, T.: Characterization of TEK receptor tyrosine kinase and its ligands, angiopoietins, in human hematopoietic progenitor cells. Int. Immunol. 10 (8), 1217-1227 (1998)
213. Sato, Y., Rifkin, D.B.: Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J. cell Biol. 107, 1199-1205 (1988)
214. Sato, Y., Rifkin, D.B.: Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J. Cell Biol. 109 (1), 309-315 (1989)
215. Sato, Y., Tsubio, R., Lyons, R., Moses, H., Rifkin, D.B.: Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J. Cell Biol. 111, 757-763 (1990)
216. Savill, Nicholas, J., Hogeweg, Paulien: Modelling morphogenesis: From single cells to crawling slugs. J. Theor. Biol. 184, 229-235 (1997)
217. Sawano, A., Iwai, S., Sakurai, Y., Ito, M., Shitara, K., Nakahata, T., Shibuya, M.: Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 97 (3), 785-791 (2001)
218. Schlessinger, J., Lax, I., Lemmon, M.: Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell 3, 357-60 (1995), Review
219. Schwartz, M.A., Ingber, D.E.: Integrating with integrins. Mol. Biol. Cell 5, 389-393 (1994)
220. Seandel, M., Noack-Kunnmann, K., Zhu, D., Aimes, R.T., Quigley, J.P.: Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. Blood 97, 2323-2332 (2001)
221. Senger, D.R., Claffey, K.P., Benes, J.E., Perruzzi, C.A., Sergiou, A.P., Detmar, M.: Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc. Natl. Acad. Sci. USA 94, 13612-13617 (1997)
222. Sephy, P.: Angiogenesis inhibitors in oncology: The research continues. Cancer Practice 8 (3), 148-150 (2000)
223. Servant, G., Weiner, O.D., Herzmark, P., Balla, T., Sedat, J.W., Bourne, H.R.: Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. Science 287 (5455), 1037-1040 (2000)
224. Sheetz, M.P., Felsenfeld, D., Galbraith, C.G., Choquet, D.: Cell migration as a five-step cycle. Biochem. Soc. Symp. 65, 233-243 (1999)
225. Shen, B.Q., Lee, D.Y, Gerber. H.P., et al.: Homologous up-regulation of KDR/FLK-1 receptor expression by vascular endothelial growth factor in vitro. J. Biol. Chem. 273, 29979-29985 (1998)
226. Shichiri, M., Hirata, Y: Antiangiogenesis signals by endostatin. FASEB J. 15 (6), 1044-1053 (2001)
227. Sholley, M.M., Ferguson, G.P., Seibel, H.R., Montour, J.L., Wilson, J.D.: Mechanisms of neovascularization. vascular sprouting can occur without proliferation of endothelial cells. Lab. Invest. 51 (6), 624-634 (1984)
228. Sleeman, B.D., Anderson, A.R.A., Chaplain, M.A.J.: A mathematical analysis of a model for capillary network formation in the absence of endothelial cell proliferation. Appld. Math. Letts. 12, 121-127 (1999)
229. Stack, M.S., Gately, S., Bafetti, L.M., Enghild, J.J., Soff, G.A.: Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation. J. Biochem. 340, 77-84 (1999)
230. Stetler-Stevenson, W.G.: Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J. Clin. Invest. 9, 1237-1241 (1999)
231. Stokes, C.L., Lauffenburger, D.A.: Analysis of the roles of microvessel endothelial cell random motility and chemotaxis in angiogenesis. J. Theor. Biol. 152, 377-403 (1991)
232. Stratmann, A., Risau, W., Plate, K.H.: Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol. 153 (5), 1459-1466 (1998)
233. Tamada, V., Fukiage, C., Boyle, D.L., Azuma, M., Shearer, T.R.: Involvement of cysteine proteases in bFGF-induced angiogenesis in guinea pig and rat cornea. J. Ocular Pharmacol. Therapeutics 16, 271-283 (2000)
234. Tanaka, S., Mori, M., Sakamoto, Y., Makuuchi, M.N., Sugimachi, K., Wands, J.R.: Biological significance of angiopoietin-2 expression in human hepatocellular carcinoma. J. Clin. Invest. 103, 341-345 (1999)
235. Taylor, S., Folkman, J.: Protamine is an inhibitor of angiogenesis. Nature 287, 307-312 (1982)
236. Tennant, T.R., Rinker-Schaeffer, C.W., Stadler, W.M.: Angiogenesis inhibitors. Curr. Onco. Rpts. 2, 11-16 (2000)
237. Thomas, W.E.: Brain macrophages: on the role of pericytes and perivascular cells. Brain Res. Brain Res. Rev. 31 (1), 42-57 (1999)
238. Thompson, W.D., Li, W.W., Maragoudakis, M.: The clinical manipulation of angiogenesis: pathology, side-effects, surprises and opportunities with novel human therapies. J. Pathol. 190, 330-337 (2000)
239. Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T.N., Yancopoulos, G.D., McDonald, D.M.: Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286 (5449), 2511-2514 (1999)
240. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J.C., Abraham, J.A.: The human gene for vascular endothelial growth-factor multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 11947-11954 (1991)
241. Toi, M., Inada, K., Suzuki, H., Tominaga, T.: Tumour angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res. Treat 36, 193-204 (1995)
242. Tong, S., Yuan, F.: Numerical simulations of angiogenesis in the cornea. Microvasc. Res. 1-14 (2000)
243. Trinchieri, G.: Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70, 83-243 (1998)
244. Turing, A.M.: The chemical basis of morphogenesis. Philosophical transactions of the Royal Society of London Series B, Biological Sciences 237, 37-72 (1952)
245. Ueno, T., Toi, M., Saji, H., Muta, M., Bando, H., Kuroi, K., Koike, M., Inadera, H., Matsushima, K.: Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin. Cancer Res. 6, 3282-3289 (2000)
246. 3: angiogenesis and apoptosis. Cell Adhes. Commun. 3, 367-374 (1995)
247. Veikkola, T., Alitalo, K.: VEGF's, receptors and angiogenesis. Sem. Cancer Biol. 9, 211-220 (1999)
248. Vernon, R.B., Sage, H.E.: A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices. Microvasc. Res. 57, 118-133 (1999)
249. Voest, E.E., Kenyon, B.M., O'Reilly, M.S., Truitt, G., D'Amato, R.J., Folkman, J.: Inhibition of angiogenesis in vivo by interleukin 12. Natl. Cancer Inst. 87, 581-586 (1995)
250. Volpert, O.V., Stellmach, V., Bouck, N.: The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression. Breast Cancer Res. Treat. 36, 119-126 (1995)
251. Weninger, W., Pammer, J., Baghestanian, M., Uthman, M., Mildner, A., Ballaun, C., Bankl, H.C., Valent, P.: Expression of vascular endothelial growth factor (VEGF) by human mast cells. J. Vasc. Res. 33, 422 (1996)
252. Werb, Z.: ECM and cell surface proteolysis: Regulating cellular ecology. Cell 91 (4), 439-442 (1997)
253. Westermark, B., Siegbahn, A., Heldin, C.H., Claesson-Welsh, L.: B-type receptor for platelet-derived growth factor mediates a chemotactic response by means of ligand-induced activation of the receptor protein-tyrosine kinase. Proc. Natl. Acad. Sci. U S A 87 (1), 128-132 (1990)
254. Willam, C., Koehne, P., Jurgensen, J.S., Grafe, M., Wagner, K.D., Bachmann, S., Frei, U., Eckardt, K.U.: Tie2 receptor expression is stimulated by hypoxia and proinflammatory cytokines in human endothelial cells. Circ. Res. 87 (5), 370-377 (2000)
255. Wong, A.L., Haroon, Z.A., Werner, S., Dewhirst, M.W., Greenberg, C.S., Peters, K.G.: Tie-2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ. Res. 81, 567-574 (1997)
256. Wong, M.P., Cheung, K.N., Yuen, S.T., Fu, K.H., Chan, A.S., Leung, S.Y., Chung, L.P.: Monocyte chemoattractant protein-1 (MCP-1) expression in primary lymphoepithelioma-like carcinomas (LELCs) of the lung. J. Pathol. 186 (4), 372-377 (1998)
257. Wu, Pl, Yonekura, H., Li, H., Nozaki, I., Tomono, Y., Naito, I., Ninomyia, Y., Yamamoto, H.: Hypoxia down-regulates endostatin production by human micro vascular endothelial cells and pericytes. Biochem. Biophys. Res. Comm. 288, 1149-1154 (2001)
258. Yamagishi, S., Yonekura, H., Yamamoto, Y., Fujimori, H., Sakurai, S., Tanaka, N., Yamamoto, H.: Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions. Lab. Invest. 79 (4), 501-509 (1999)
259. Yamagushi, N., Anand-Apte, B., Lee, M., Sasaki, T., Fukai, N., Shapiro, R., Que, I., Lowik, C., Timpl, R., Olsen, B.R.: Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. The EMBO Journal 18 (16), 4414-4423 (1999)
260. Yancopoulos, G.D., Davis, S., Gale, N.W., Rudge, J.S., Weigand. S.J., Holash, J.: Vascular-specific growth factors and blood-vessel formation. Nature 407 (6801), 242-248 (2000), Review
261. Yang, S., Graham, J., Kahn, J.W., Schwartz, E.A., Gerritsen, M.E.: Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am. J. Pathology 155, 887-895 (1999)
262. Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N., Jain, R.K.: Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl. Acad. Sci. USA 93, 14765-14770 (1996)
263. Zawicki, D.F., Jain, R.K., Shmid-Schoenbein, Chiem, S.: Dynamics of neovascularization in normal tissue. Microvasc. Res. 21, 27-47 (1981)
264. Zhang, Y., Deng, Y., Luther, T., Muller, M., Ziegler, R., Waldherr, R., Stern, D.M.: Nawroth PP. tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J. Clin. Invest. 94 (3), 1320-1327 (1994)
265. Zhu, C., Bao, G., Wang, N.: Cell mechanics: mechanical response, cell adhesion, and molecular deformation. Annu. Rev. Biomed. Eng. 2, 189-226 (2000)
266. Zimmerman, K.: Der peinere bau der blutcapillaren. A. Anat. Entwicklungsgesh. 68, 29-109 (1923)